A Phase 2a, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Pilot Efficacy, Safety, Tolerability, And Pharmacokinetics Of 2% Tofacitinib Ointment In Subjects With Mild To Moderate Atopic Dermatitis

Trial Profile

A Phase 2a, Multi-site, Randomized, Double-blind, Vehicle-controlled, Parallel-group Study Of The Pilot Efficacy, Safety, Tolerability, And Pharmacokinetics Of 2% Tofacitinib Ointment In Subjects With Mild To Moderate Atopic Dermatitis

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Atopic dermatitis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 18 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 16 Jun 2014 Planned End Date changed from 1 May 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
    • 08 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top